190 related articles for article (PubMed ID: 33350884)
1. Expression of Interleukin 6 signaling receptors in carotid atherosclerosis.
Ziegler L; Lundqvist J; Dreij K; Wallén H; de Faire U; Paulsson-Berne G; Hedin U; Matic L; Gigante B
Vasc Med; 2021 Feb; 26(1):3-10. PubMed ID: 33350884
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 trans-signalling and risk of future cardiovascular events.
Ziegler L; Gajulapuri A; Frumento P; Bonomi A; Wallén H; de Faire U; Rose-John S; Gigante B
Cardiovasc Res; 2019 Jan; 115(1):213-221. PubMed ID: 30052808
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction.
Moreno Velásquez I; Golabkesh Z; Källberg H; Leander K; de Faire U; Gigante B
Atherosclerosis; 2015 Jun; 240(2):477-81. PubMed ID: 25910182
[TBL] [Abstract][Full Text] [Related]
4. Levels of Soluble Interleukin 6 Receptor and Asp358Ala Are Associated With Cognitive Performance and Alzheimer Disease Biomarkers.
Quillen D; Hughes TM; Craft S; Howard T; Register T; Suerken C; Hawkins GA; Milligan C
Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 36810164
[TBL] [Abstract][Full Text] [Related]
5. Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130.
Van Zaanen HC; Lokhorst HM; Aarden LA; Rensink HJ; Warnaar SO; Van Oers MH
Leuk Lymphoma; 1998 Nov; 31(5-6):551-8. PubMed ID: 9922045
[TBL] [Abstract][Full Text] [Related]
6. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
[TBL] [Abstract][Full Text] [Related]
7. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of interleukin 6 and its receptor at the maternal-conceptus interface during pregnancy in pigs.
Yoo I; Han J; Kim M; Jang H; Sa S; Choi SH; Ka H
Theriogenology; 2017 Jul; 96():85-91. PubMed ID: 28532843
[TBL] [Abstract][Full Text] [Related]
9. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils.
Chalaris A; Rabe B; Paliga K; Lange H; Laskay T; Fielding CA; Jones SA; Rose-John S; Scheller J
Blood; 2007 Sep; 110(6):1748-55. PubMed ID: 17567983
[TBL] [Abstract][Full Text] [Related]
11. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness.
Weiss TW; Arnesen H; Seljeflot I
Metabolism; 2013 Jul; 62(7):1008-13. PubMed ID: 23428306
[TBL] [Abstract][Full Text] [Related]
12. IL6/sIL6R regulates TNFα-inflammatory response in synovial fibroblasts through modulation of transcriptional and post-transcriptional mechanisms.
Valin A; Del Rey MJ; Municio C; Usategui A; Romero M; Fernández-Felipe J; Cañete JD; Blanco FJ; Ruano Y; Criado G; Pablos JL
BMC Mol Cell Biol; 2020 Oct; 21(1):74. PubMed ID: 33126846
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-6/interleukin-6-receptor system is activated in donor hearts.
Plenz G; Eschert H; Erren M; Wichter T; Böhm M; Flesch M; Scheld HH; Deng MC
J Am Coll Cardiol; 2002 May; 39(9):1508-12. PubMed ID: 11985915
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic Acid and IL-6 Trans-signaling Interact via YAP/TAZ and STAT3 Signaling Pathways in Human Trabecular Meshwork Cells.
Yemanyi F; Raghunathan V
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):29. PubMed ID: 33216119
[TBL] [Abstract][Full Text] [Related]
15. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
[TBL] [Abstract][Full Text] [Related]
16. Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression.
Tsukamoto H; Fujieda K; Hirayama M; Ikeda T; Yuno A; Matsumura K; Fukuma D; Araki K; Mizuta H; Nakayama H; Senju S; Nishimura Y
Cancer Res; 2017 May; 77(9):2279-2291. PubMed ID: 28235765
[TBL] [Abstract][Full Text] [Related]
17. Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130.
Widjaja AA; Cook SA
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338642
[TBL] [Abstract][Full Text] [Related]
18. IL6 receptor
Wosiski-Kuhn M; Robinson M; Strupe J; Arounleut P; Martin M; Caress J; Cartwright M; Bowser R; Cudkowicz M; Langefeld C; Hawkins GA; Milligan C
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):e631. PubMed ID: 31611269
[TBL] [Abstract][Full Text] [Related]
19. Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis.
Korotaeva AA; Samoilova EV; Chepurnova DA; Zhitareva IV; Shuvalova YA; Prokazova NV
Biomarkers; 2018 Sep; 23(6):527-532. PubMed ID: 29580104
[TBL] [Abstract][Full Text] [Related]
20. Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.
Rabe B; Chalaris A; May U; Waetzig GH; Seegert D; Williams AS; Jones SA; Rose-John S; Scheller J
Blood; 2008 Feb; 111(3):1021-8. PubMed ID: 17989316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
